The Stem Cell Injection using Wharton’s Jelly with Exosomes is an advanced regenerative therapy designed to repair, restore, and regenerate damaged or degenerated tissues at the cellular level. Wharton’s Jelly, derived from ethically sourced umbilical tissue, is rich in mesenchymal stem cells, growth factors, cytokines, and extracellular matrix components that support tissue healing and reduce inflammation.
When combined with exosomes ~ the bioactive vesicles naturally secreted by stem cells that carry regenerative signaling molecules ~ the formulation delivers enhanced cellular communication, growth factor activation, and accelerated healing response. This therapy is performed under ultrasound guidance for precise placement into targeted joints, tendons, or soft tissue structures.
Common Treatment Areas:
Knees, shoulders, hips, elbows, wrists, ankles, and spinal or soft tissue injuries associated with chronic inflammation, arthritis, or overuse.
Recommended Treatment Plan:
Typically performed as a single injection, though some patients may benefit from additional sessions spaced 3–6 months apart, depending on tissue response and severity of degeneration.
Treatment Time: 45–60 minutes
Downtime: Minimal ~ mild soreness or swelling may occur for 24–72 hours
Results: Progressive improvement in pain, mobility, and function over several weeks to months as regenerative activity continues
Consultation Requirement:
A consultation is required prior to treatment to review medical history, imaging, and determine candidacy for Wharton’s Jelly + Exosome therapy.
Before Your Appointment:
Arrive well-hydrated and avoid NSAIDs, corticosteroids, alcohol, and blood-thinning supplements for at least 1 week prior and 1 week post-procedure to preserve regenerative cell activity. Notify your provider if you are currently taking antibiotics, steroids, or anticoagulant therapy.
Contraindications:
Not recommended for individuals who are pregnant, breastfeeding, have uncontrolled diabetes, active infection, autoimmune flare, bleeding disorders, or are on anticoagulant therapy.